Mouse Anti-GRK3 Recombinant Antibody (CAP223) (V2LY-0226-LY1323)

Rabjohns, E. M., Rampersad, R. R., Ghosh, A., Hurst, K., Eudy, A. M., Brozowski, J. M., ... & Tarrant, T. K. (2023). Aged G Protein-Coupled Receptor Kinase 3 (Grk3)-Deficient Mice Exhibit Enhanced Osteoclastogenesis and Develop Bone Lesions Analogous to Human Paget’s Disease of Bone. Cells, 12(7), 981.

Gazdarica, M., Noda, J., Durydivka, O., Novosadova, V., Mackie, K., Pin, J. P., ... & Blahos, J. (2022). SGIP1 modulates kinetics and interactions of the cannabinoid receptor 1 and G protein‐coupled receptor kinase 3 signalosome. Journal of Neurochemistry, 160(6), 625-642.

Brozowski, J. M., Timoshchenko, R. G., Serafin, D. S., Allyn, B., Koontz, J., Rabjohns, E. M., ... & Tarrant, T. K. (2022). G protein-coupled receptor kinase 3 modulates mesenchymal stem cell proliferation and differentiation through sphingosine-1-phosphate receptor regulation. Stem cell research & therapy, 13(1), 37.

Ihara, S., & Touhara, K. (2018). G Protein-Coupled Receptor Kinase 3 (GRK3) in Olfaction. Olfactory Receptors: Methods and Protocols, 33-41.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols